7893159 Canada Inc.: federal grants and contributions

Updated 12 October 2026 · Montréal, No MRC, Montréal, QC · grants and contributions register · Ville-Marie–Le Sud-Ouest–Île-des-Soeurs

7893159 Canada Inc.: federal grants and contributions: 6 agreements; $1.6M value; 2 departments; 4 programs.

Assay record ASY-CA-19JZFN51AE · Cite as: Assay Systems, “7893159 Canada Inc.: federal grants and contributions”, https://assay-systems.com/register/ca/grants/r/7893159-canada-inc/

$
6agreements
$1.6Mvalue
2departments
4programs

Largest agreements

EUREKA ITEA 17010 SAMUEL : Smart Additive Manufacturing – an AM Intelligent Platform.$962Kvalue2019start2023end

Additive manufacturing (AM) is becoming mainstream. However, there is a clear need to create accessible expertise on “which technology for which application for AM process/technology/material”. The SAMUEL project captures the engineer’s experience through data-mining, machine-learning, and advanced analysis to create an AM knowledge base that can assist an engineer or a business in all major AM steps. This project is part of the EUREKA Cluster ITEA project 17010 SAMUEL

Eurostars E!114874 RUD$350Kvalue2021start2023end

This project is a portion of the EUROSTARS PROJECT Nº E! 114874 RUD entitled “RESTRUCTURING UNSTRUCTURED GRAPHICAL DOCUMENTS”, led by APPLICATIONS & INNOVATIONS INDUSTRIELLES & INFORMATIQUES (French SME & Lead). This project aims to develop innovative technologies capable of revealing semantics and extracting knowledge in deconstructed documents containing 2D/3D models. It will promote data analytics and AI approaches for this type of data.

Quebec Economic Development Program (QEDP)$168Kvalue2014start–end

Monies allocated over more than one fiscal year;Repayable Contribution

Business and Regional Growth Program (CED-Business)$100Kvalue2012start–end

Monies allocated over more than one fiscal year;Repayable Contribution

Agreement$50.0Kvalue2016start–end
EUREKA Cluster - ITEA – Participation in ITEA 2023 PO Days in Berlin$3.0Kvalue2023start2023end

Participation in the ITEA PO Days held in Berlin, Germany, Sept 11-15, 2023. Delegation led by the National Research Council of Canada Industrial Research Assistance Program (NRC IRAP) to help establish relationships with key customers, end-users, and other international firms, which will help set the stage for potential Canadian projects in the upcoming EUREKA ITEA Cluster call for proposals. Each year the Board Support Group together with the Steering Group, nominates three outstanding ITEA projects for the ITEA Awards of Excellence. This year SAMUEL project is selected for the Innovation fo

Departments

National Research Council Canada4agreements$1.4Mvalue2programs
  • Industrial Research Assistance Program – Contributions to Firms
  • Eureka/Eurostar

All grants from National Research Council Canada

Canada Economic Development for Quebec Regions2agreements$268Kvalue2programs
  • Quebec Economic Development Program (QEDP)
  • Business and Regional Growth Program (CED-Business)

All grants from Canada Economic Development for Quebec Regions

Years

20231agreements$3.0Kvalue1programs
  • Industrial Research Assistance Program – Contributions to Firms
20211agreements$350Kvalue1programs
  • Eureka/Eurostar
20191agreements$962Kvalue1programs
  • Industrial Research Assistance Program – Contributions to Firms
20161agreements$50.0Kvalue0programs
    20141agreements$168Kvalue1programs
    • Quebec Economic Development Program (QEDP)
    20121agreements$100Kvalue1programs
    • Business and Regional Growth Program (CED-Business)

    Contains information licensed under the Open Government Licence – Canada. Source: Government of Canada proactive disclosure of grants and contributions (open.canada.ca, dataset 432527ab-7aac-45b5-81d6-7597107a7013), 1,327,352 rows as published, collapsed to one agreement per agreement number (per reference number where none is given) at its latest amendment, which carries the full agreement value. Years are the agreement start year. Agreements with individuals are counted but not named.